PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Disease Unit, Azienda Ospedaliera Di Caserta S. Anna e S. Sebastiano, Caserta, Italy.\', \'Department of Advanced Medical and Surgery Science, Internal Medicine Covid Center, University of Campania Luigi Vanvitelli, 80100, Naples, Italy. riccardo.nevola@unicampania.it.\', \'Infectious Diseases, 3Rd Covid Center Ospedale Cotugno, Naples, Italy.\', \'COVID Center, Ospedale Di Maddaloni, Caserta, Italy.\', \'Department of Advanced Medical and Surgery Science, Internal Medicine Covid Center, University of Campania Luigi Vanvitelli, 80100, Naples, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-022-09741-5
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 35388092
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all